News & AnalysisBiomedical Research

NIH to Phase Out Most Chimp Research

See allHide authors and affiliations

Science  05 Jul 2013:
Vol. 341, Issue 6141, pp. 17-18
DOI: 10.1126/science.341.6141.17

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

This article has a correction. Please see:


Chimpanzees are not necessary for almost all biomedical research, NIH Director Francis Collins said last week in announcing the agency's plan to retire all but 50 of the 360 animals it has available for research. Few, if any, invasive experiments will remain. Eight noninvasive behavioral and genomics studies can continue, NIH said, but only if the chimpanzees are kept in appropriate conditions, such as in groups of at least seven animals, in large outdoor spaces, and with room to climb. The decision comes after years of debate. Explaining the decision, Collins said that chimpanzees share 98% of our DNA, and "they deserve special respect." Reducing their use in research is "scientifically sound and the right thing to do."

View Full Text

Stay Connected to Science